Sipuleucel-T in prostate cancer: Indication of added benefit
Friday, March 20, 2015 - 11:30
in Health & Medicine
Regarding Sipuleucel-T for use in prostate cancer, information submitted by the drug manufacturer provided better evidence on mortality. However, it is not possible to exactly estimate the extent of added benefit.